COVID-19: WHO Expects Anti-malarial Drug Hydroxychloroquine Safety Findings By Mid-June

"A final decision on the harm, benefit or lack of benefit of hydroxychloroquine will be made once the evidence has been reviewed by the Data Safety Monitoring Board," the body said in a statement. "It is expected by mid-June."

from covid-19 https://ift.tt/2XxGYon